Terms: = Gastric cancer AND MUC16, CA125, CA-125 AND Staging
12 results:
1. Detection Rate and Prognosis of Lymph Nodes in gastric cancer Using Nano Carbon Combined with
Ma J; Ren C; Du G; Wang J; Han Z; Li H; Li H; Xue L
Comput Intell Neurosci; 2022; 2022():4540176. PubMed ID: 36052030
[TBL] [Abstract] [Full Text] [Related]
2. Usefulness of Diagnostic staging Laparoscopy for Advanced gastric cancer.
Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nishi M; Takasu C; Kashihara H; Eto S; Yoshimoto T
Am Surg; 2023 Apr; 89(4):685-690. PubMed ID: 34382447
[TBL] [Abstract] [Full Text] [Related]
3. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from gastric cancer.
Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
[TBL] [Abstract] [Full Text] [Related]
4. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
Xue T; Yang J; Song P; Zhou G
J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of gastric Adenocarcinoma staging and Grading.
Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F
J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060
[TBL] [Abstract] [Full Text] [Related]
6. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese gastric cancer Association.
Shimada H; Noie T; Ohashi M; Oba K; Takahashi Y
Gastric Cancer; 2014 Jan; 17(1):26-33. PubMed ID: 23572188
[TBL] [Abstract] [Full Text] [Related]
8. [Gastrointestinal cancer].
Takahashi Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of serum CA72-4, CEA, TPA, CA19-9 and ca125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract] [Full Text] [Related]
10. [Utility of measurement of tumor markers for preoperative staging of gastric cancer].
Yano T; Nakatani K; Watanabe A; Sawada H; Okumura T; Yamada Y; Nakano H
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):977-87. PubMed ID: 8246875
[TBL] [Abstract] [Full Text] [Related]
11. [Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line].
Mai M; Takahashi Y
Hum Cell; 1993 Jun; 6(2):82-7. PubMed ID: 7692953
[TBL] [Abstract] [Full Text] [Related]
12. Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125.
Szymendera JJ
Tumour Biol; 1986; 7(5-6):333-42. PubMed ID: 2437641
[TBL] [Abstract] [Full Text] [Related]
